Your browser doesn't support javascript.
loading
Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties.
Wawruszak, Anna; Gumbarewicz, Ewelina; Okon, Estera; Jeleniewicz, Witold; Czapinski, Jakub; Halasa, Marta; Okla, Karolina; Smok-Kalwat, Jolanta; Bocian, Artur; Rivero-Muller, Adolfo; Stepulak, Andrzej.
Afiliação
  • Wawruszak A; Department of Biochemistry and Molecular Biology, Medical University of Lublin, Lublin, Poland.
  • Gumbarewicz E; Department of Biochemistry and Molecular Biology, Medical University of Lublin, Lublin, Poland.
  • Okon E; Department of Biochemistry and Molecular Biology, Medical University of Lublin, Lublin, Poland.
  • Jeleniewicz W; Department of Biochemistry and Molecular Biology, Medical University of Lublin, Lublin, Poland.
  • Czapinski J; Department of Biochemistry and Molecular Biology, Medical University of Lublin, Lublin, Poland.
  • Halasa M; School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland.
  • Okla K; Department of Biochemistry and Molecular Biology, Medical University of Lublin, Lublin, Poland.
  • Smok-Kalwat J; The First Department of Gynecologic Oncology and Gynecology, Medical University of Lublin, Lublin, Poland.
  • Bocian A; Tumor Immunology Laboratory, Medical University of Lublin, Lublin, Poland.
  • Rivero-Muller A; Department of Clinical Oncology, Holy Cross Cancer Centre, Kielce, Poland.
  • Stepulak A; Department of Oncological Surgery, Holy Cross Cancer Centre, Kielce, Poland.
Cancer Manag Res ; 11: 8345-8358, 2019.
Article em En | MEDLINE | ID: mdl-31571991
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article